SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001214659-16-010949
Filing Date
2016-04-22
Accepted
2016-04-22 17:16:40
Documents
4
Period of Report
2016-04-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 m4211608k.htm 8-K 29418
2 EXHIBIT 5.1 ex5_1.htm EX-5.1 14508
3 EXHIBIT 10.1 ex10_1.htm EX-10.1 232339
4 logo.jpg GRAPHIC 5612
  Complete submission text file 0001214659-16-010949.txt   285288
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34637 | Film No.: 161587309
SIC: 2834 Pharmaceutical Preparations